The clinical trial of Bharat Biotech’s COVAXIN on children began at AIIMS Patna. All 15 kids who voluntarily turned up for the vaccine trial had gone through the screening process such as RT-PCR, antibody test and general check up prior to receiving their shots.
Three children were found fit for vaccine trials after screening. Children found with antibodies could not participate in the vaccine trial. Dr Sanjeev Kumar, nodal-in-charge for COVID at AIIMS, Patna said, the children who received their first shot are in the age group of 12 to 18 years. After being administered 0.5.ml dose of intramuscular injection, the children were monitored for two hours.
The second dose will be given after four weeks. During this period their health will be closely monitored.